Key Events This Week
27 Jan: Stock rises 2.43% on solid volume
28 Jan: Q3 FY26 results reveal stellar profit surge
29 Jan: Intraday low hit amid sharp price pressure
30 Jan: Week closes lower at Rs.419.30 (-5.24%)
Are Thyrocare Technologies Ltd latest results good or bad?
2026-01-29 19:23:10Thyrocare Technologies Ltd's latest financial results for Q3 FY26 indicate a notable performance, characterized by significant operational growth and efficiency. The company reported a net profit of ₹47.99 crores, reflecting a substantial year-on-year increase of 79.94%. This growth was supported by a revenue increase of 22.09%, reaching ₹216.53 crores, which also demonstrated robust sequential momentum with a 12.17% rise compared to the previous quarter. The operational metrics highlight an operating margin of 32.95%, which is a marked improvement from the prior year's 27.23%, showcasing effective cost management and enhanced asset utilization. Additionally, the profit after tax margin improved significantly to 22.08%, up from 14.90% in the same quarter last year, indicating better earnings quality driven by operational efficiency and a normalized tax rate. On a half-yearly basis, Thyrocare's consolidate...
Read full news article
Thyrocare Technologies Ltd Hits Intraday Low Amid Price Pressure
2026-01-29 11:01:30Thyrocare Technologies Ltd experienced a notable decline today, hitting an intraday low of Rs 428, down 6.79% from its previous close, reflecting significant price pressure amid a broadly negative market environment.
Read full news article
Thyrocare Technologies Q3 FY26: Profit Surge Masked by Sequential Slowdown
2026-01-28 19:02:44Thyrocare Technologies Ltd., India's leading diagnostic services provider, reported consolidated net profit of ₹29.01 crores for Q3 FY26 (October-December 2025), marking a robust year-on-year growth of 51.81% from ₹19.11 crores in Q3 FY25. However, the quarter-on-quarter narrative reveals a different story, with profits declining sharply by 39.55% from ₹47.99 crores in Q2 FY26. The stock, currently trading at ₹403.00 with a market capitalisation of ₹6,659 crores, has delivered exceptional returns of 81.97% over the past year, significantly outperforming the Sensex's 8.49% gain by a commanding 73.48 percentage points.
Read full news article
Thyrocare Technologies Ltd is Rated Buy
2026-01-25 10:10:30Thyrocare Technologies Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 10 Nov 2025. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 25 January 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.
Read full news article
Thyrocare Technologies Ltd Sees Mixed Technical Signals Amid Mild Momentum Shift
2026-01-22 08:01:38Thyrocare Technologies Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late January 2026. Despite a recent day decline of 3.13%, the stock’s broader technical indicators and price action suggest a cautiously optimistic outlook, supported by mixed signals from key momentum oscillators and moving averages. This analysis delves into the evolving technical landscape of Thyrocare, contextualising its performance against sector peers and the broader market.
Read full news articleWhen is the next results date for Thyrocare Technologies Ltd?
2026-01-21 23:16:28The next results date for Thyrocare Technologies Ltd is scheduled for 28 January 2026....
Read full news article
Thyrocare Technologies Ltd Sees Bullish Momentum Shift Amid Technical Upgrades
2026-01-21 08:04:04Thyrocare Technologies Ltd has exhibited a notable shift in its technical momentum, transitioning from a mildly bullish to a bullish trend, supported by a confluence of key indicators such as MACD, RSI, moving averages, and Bollinger Bands. This technical evolution, coupled with strong long-term returns relative to the Sensex, underscores a positive outlook for the healthcare services company as it navigates the current market environment.
Read full news article
Thyrocare Technologies Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals
2026-01-19 08:03:12Thyrocare Technologies Ltd has experienced a subtle shift in its price momentum, transitioning from a bullish to a mildly bullish technical trend. Despite a slight dip in the daily price, the stock’s broader technical indicators present a nuanced picture, reflecting mixed signals across key metrics such as MACD, RSI, and moving averages. This development invites a closer examination of the stock’s technical health and its implications for investors in the healthcare services sector.
Read full news article





